Richard Paolone is a Toronto-based securities lawyer with extensive experience in corporate finance, securities law, and mergers and acquisitions. Mr. Paolone plays a key role in advising on a range ...
Entero Therapeutics, Inc. (Nasdaq: ENTO) ("Entero" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of ...
BOCA RATON, Fla. - Entero Therapeutics, Inc. (NASDAQ:ENTO), a clinical-stage biopharmaceutical company with a market capitalization of $2.45 million, today announced the appointment of Richard Paolone ...
News Medical on MSN2h
Study reveals opsin 3's role in mouse appetite controlScientists discovered years ago that the hypothalamus—which helps to manage body temperature, hunger, sex drive, sleep and ...
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback